Infection in systemic lupus erythematosus

Research output: Contribution to journalArticle

Abstract

The improved survival of SLE patients since the 1950s is the result of not only better treatment, but also supportive treatment of renal failure and the wealth of antibiotics now available. Ironically, the wider use of immunosuppressives, especially the alkylating drugs, and the longer survival of patients with renal insufficiency and renal failure have made the identification and appropriate treatment of infection in SLE an ongoing challenge.

Original languageEnglish (US)
Pages (from-to)423-456
Number of pages34
JournalRheumatic Disease Clinics of North America
Volume24
Issue number2
DOIs
StatePublished - 1998

Fingerprint

Systemic Lupus Erythematosus
Renal Insufficiency
Infection
Survival
Immunosuppressive Agents
Treatment Failure
Anti-Bacterial Agents
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Rheumatology

Cite this

Infection in systemic lupus erythematosus. / Petri, Michelle.

In: Rheumatic Disease Clinics of North America, Vol. 24, No. 2, 1998, p. 423-456.

Research output: Contribution to journalArticle

@article{904771dff10d40bbb4351e262fb0d16c,
title = "Infection in systemic lupus erythematosus",
abstract = "The improved survival of SLE patients since the 1950s is the result of not only better treatment, but also supportive treatment of renal failure and the wealth of antibiotics now available. Ironically, the wider use of immunosuppressives, especially the alkylating drugs, and the longer survival of patients with renal insufficiency and renal failure have made the identification and appropriate treatment of infection in SLE an ongoing challenge.",
author = "Michelle Petri",
year = "1998",
doi = "10.1016/S0889-857X(05)70016-8",
language = "English (US)",
volume = "24",
pages = "423--456",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Infection in systemic lupus erythematosus

AU - Petri, Michelle

PY - 1998

Y1 - 1998

N2 - The improved survival of SLE patients since the 1950s is the result of not only better treatment, but also supportive treatment of renal failure and the wealth of antibiotics now available. Ironically, the wider use of immunosuppressives, especially the alkylating drugs, and the longer survival of patients with renal insufficiency and renal failure have made the identification and appropriate treatment of infection in SLE an ongoing challenge.

AB - The improved survival of SLE patients since the 1950s is the result of not only better treatment, but also supportive treatment of renal failure and the wealth of antibiotics now available. Ironically, the wider use of immunosuppressives, especially the alkylating drugs, and the longer survival of patients with renal insufficiency and renal failure have made the identification and appropriate treatment of infection in SLE an ongoing challenge.

UR - http://www.scopus.com/inward/record.url?scp=0031803439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031803439&partnerID=8YFLogxK

U2 - 10.1016/S0889-857X(05)70016-8

DO - 10.1016/S0889-857X(05)70016-8

M3 - Article

VL - 24

SP - 423

EP - 456

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 2

ER -